The Relationship Between Menstrual Cycle Irregularities and COVID-19 Vaccination
Overview
Authors
Affiliations
Background After COVID-19 vaccination, females reported irregularities and changes in their menstrual cycle. We aimed to explore the menstrual irregularities following COVID-19 vaccination in Saudi women of childbearing age. Methodology The study was a cross-sectional study conducted among women in Riyadh, Saudi Arabia, who had no history of menstrual irregularities before receiving the first dose of the COVID-19 vaccine. The participants filled out an online self-administered questionnaire via Google Form about any menstrual irregularities they experienced after receiving the COVID-19 vaccine. Results A total of 535 participants completed the survey. The study found that 41.7% (223) of women experienced menstrual changes after the first dose of the COVID-19 vaccine, increasing to 44.1% (236) after the second dose. The incidence of these changes varied between the first and second doses. For example, the incidence of changes in period duration decreased from 51.6% to 48.3% after the first and second doses, respectively. Similarly, the incidence of delayed periods decreased from 48.4% to 47.9%, while dysmenorrhea increased slightly from 30.9% to 32.2% after the two doses. The incidence of heavier menstrual flow increased from 26.9% to 30.5%, while the incidence of lighter menstrual flow decreased from 26.9% to 24.6% after the first and second doses, respectively. Conclusions There is an increased incidence of changes in menstrual cycle after COVID-19 vaccination, particularly in menstrual cycle length, menstrual pain, and the flow of menstruation. Future studies are needed to investigate the potential underlying biological mechanisms.
COVID-19 and persistent symptoms: implications for polycystic ovary syndrome and its management.
Zhang S, Wu Y, Mprah R, Wang M Front Endocrinol (Lausanne). 2024; 15:1434331.
PMID: 39429741 PMC: 11486749. DOI: 10.3389/fendo.2024.1434331.
Aftab N, Fahad A, Al Hammadi S, Tahlak M, Badawi F, Al Mulai I Cureus. 2024; 15(12):e51391.
PMID: 38292982 PMC: 10825384. DOI: 10.7759/cureus.51391.